Glisoxepide
Glisoxepide
![](../I/m/Glisoxepide.png) |
![](../I/m/Glisoxepide_ball-and-stick.png) |
Identifiers |
ATC code |
A10BB11 |
|
25046-79-1 Y |
ChEMBL |
ChEMBL2106618 |
ChemSpider |
30380 Y |
DrugBank |
DB01289 Y |
InChI=1S/C20H27N5O5S/c1-15-14-18(23-30-15)19(26)21-11-10-16-6-8-17(9-7-16)31(28,29)24-20(27)22-25-12-4-2-3-5-13-25/h6-9,14H,2-5,10-13H2,1H3,(H,21,26)(H2,22,24,27) YKey: ZKUDBRCEOBOWLF-UHFFFAOYSA-N YInChI=1/C20H27N5O5S/c1-15-14-18(23-30-15)19(26)21-11-10-16-6-8-17(9-7-16)31(28,29)24-20(27)22-25-12-4-2-3-5-13-25/h6-9,14H,2-5,10-13H2,1H3,(H,21,26)(H2,22,24,27) Key: ZKUDBRCEOBOWLF-UHFFFAOYAG
|
Jmol-3D images |
Image |
KEGG |
D07118 Y |
PubChem |
32778 |
O=C(NCCc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2)c3noc(c3)C
|
UNII |
H7SC0I332I Y |
Properties |
|
C20H27N5O5S |
Molar mass |
449.52388 g/mol |
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa) |
Y verify (what is: Y/ N?) |
Infobox references |
|
|
Glisoxepide (INN) is an anti-diabetic drug from the group of sulfonylureas.[1]
References
- ↑ Haupt E, Köberich W, Beyer J, Schöffling K (December 1971). "Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects". Diabetologia 7 (6): 449–54. doi:10.1007/bf01212061. PMID 5004178.
|
---|
| Insulin | |
---|
| Other | |
---|
| | | |
---|
| Description |
- Glands
- Hormones
- thyroid
- mineralocorticoids
- Physiology
- Development
|
---|
| Disease |
- Diabetes
- Congenital
- Neoplasms and cancer
- Other
- Symptoms and signs
|
---|
| Treatment |
- Procedures
- Drugs
- calcium balance
- corticosteroids
- oral hypoglycemics
- pituitary and hypothalamic
- thyroid
|
---|
|
|